A novel system for solubilizing lipid-soluble organic sun filters.

JP2023552070A5Pending Publication Date: 2024-11-20PIERRE FABRE DERMO COSMETIQUE SA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2023528271
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-11-12
Filing Date
2021-11-10
Publication Date
2024-11-20

AI Technical Summary

Technical Problem

Existing sun care products face challenges in providing effective UV protection while minimizing the use of potentially harmful sun filters, ensuring environmental safety, and maintaining user comfort and stability over time.

Method used

A novel solubilization system using C12-C15 alkyl benzoate efficiently solubilizes lipophilic UV filters in emulsion form, combining them with particulate organic UV filters to create a homogeneous, stable, and non-greasy composition that does not include ethylhexyl salicylate or octocrylene, known endocrine disruptors.

Benefits of technology

The composition provides broad-spectrum UV protection, maintains stability over time, and ensures user comfort with a non-greasy feel, while minimizing environmental impact by avoiding the use of controversial filters.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present invention relates to a cosmetic or dermatological composition in emulsion form, comprising: (a) a lipid-soluble photoprotective system, (i) hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate, (ii) 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine, (iii) butyl methoxydibenzoylmethane, (iv) ethylhexyltriazone, and (v) diethylhexylbutamidotriazone, a lipid-soluble photoprotective system consisting of one or more lipid-soluble UV filters selected from: (b) a solubilization system of the lipid-soluble photoprotective system (a), wherein C is present in an amount of 80 wt % or more, preferably 90 wt % or more, based on the total weight of the solubilization system. 12 -C 15 a solubilizing system comprising an alkyl benzoate; and (c) one or more particulate organic UV filters, in particular aqueous dispersions, (vi) 5,6,5',6'-tetraphenyl-3,3'-(1,4-phenylene)-bis[1,2,4]triazine, (vii) methylenebis-benzotriazolyltetramethylbutylphenol, and (viii) tris-biphenyltriazine, Filters to be selected from, Includes; the lipid-soluble photoprotective system (a) is present in an amount ranging from 3 wt% to 19 wt%, preferably from 5 wt% to 15 wt%, relative to the total weight of the composition; and the solubilizing system (b) is present in an amount of 15 wt% to 30 wt% relative to the total weight of the composition, It is characterized by: The composition is characterized in that it does not contain ethylhexyl salicylate, octocrylene, ethylhexyl methoxycinnamate, isoamyl methoxyl cinnamate, homosalate, para-aminobenzoic acid (PABA), octyl dimethyl PABA, 3-methylbenzylidene camphor, 4-methylbenzylidene camphor, benzophenone-3, and / or benzophenone-4.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical Field]

[0001] The present invention relates to a cosmetic or dermatological composition in emulsion form, which comprises a fat-soluble photoprotective system, a system for solubilizing said fat-soluble photoprotective system, and one or more organic particulate UV filters, in particular in aqueous dispersion. [Background technology]

[0002] The harmful effects of ultraviolet radiation on the skin are well known, and numerous sun protection products, commonly referred to as sunscreen products, are available on the market. These sunscreen products are intended for topical application and contain a combination of lipid-soluble, water-soluble, or water-insoluble organic or inorganic compounds that protect the user from UV radiation and, for this reason, qualify as sun filters.

[0003] The need to combine multiple sun filters in a given composition is explained by the fact that each filter preferentially absorbs certain wavelengths, and therefore, to effectively protect the user from all UV radiation, multiple filters must be combined to obtain the widest possible UV absorption spectrum.

[0004] Certain liquid sun filters, such as ethylhexyl salicylate or octocrylene, are known to enhance the solubilization of lipid-soluble organic filters and are the sun filters most commonly used in sun protection products, many of which are initially in powder form.

[0005] However, both ethylhexyl salicylate and octocrylene are suspected of being endocrine disruptors. Other sun filters present in many commercial products have also come under controversy due to their potentially harmful effects on users or the environment. These include, in particular, cinnamate derivatives (ethylhexyl methoxycinnamate, isoamyl methoxyl cinnamate), homosalate, para-aminobenzoic acid (PABA, octyl dimethyl PABA), camphor (3-methylbenzylidene camphor, 4-methylbenzylidene camphor), and benzophenone (benzophenone-3, benzophenone-4). The use of such compounds is therefore undesirable.

[0006] Furthermore, more generally, to obtain better results in terms of user tolerance and environmental impact, it is desirable to minimize both the number of UV filters forming the photoprotective composition and the concentration of said filters in the composition. In fact, not all organic chemical filters are completely harmless in themselves, and the risk of harmful interactions between various compounds in combination cannot be ignored. Minimizing the number and concentration of filters in sunscreen products is also beneficial for the environment, since UV filters contained in sunscreens can end up in the ocean.

[0007] For these reasons, the Applicant has focused on protecting users and the environment in developing new sun care products, and has refrained from using sun filters where their harmlessness is in doubt.

[0008] To guarantee effective protection against UV radiation, it remains necessary to obtain homogeneous compositions that are stable over time by completely solubilizing the various filters that constitute sun care compositions, in particular the liposoluble filters that are present in powder form.

[0009] In addition to the above-mentioned safety, the Applicant wanted to ensure the comfort of the user by proposing a sun care product that is particularly easy to apply and that, once applied, provides an optimal feel, giving the skin a tactilely and visually non-greasy and non-sticky appearance. Summary of the Invention [Problem to be solved by the invention]

[0010] The Applicant has therefore developed a novel sunscreen composition that provides efficient protection for the user from UV radiation, comprising a novel solubilization system that is able to efficiently solubilize a lipophilic UV filter in powder form while having an optimal feel. It should be noted that the concept of the efficiency of the solubilization system also includes the stability of the solution obtained by solubilizing the lipophilic UV filter in the solubilization system, which also encompasses that the filter does not recrystallize over time.

[0011] Surprisingly and unexpectedly, the Applicant has discovered that C 2 O 3 is an agent for solubilizing fat-soluble UV filters in compositions in emulsion form. 12 -C 15 Alkyl benzoates are now available (C 12 -C 15 It has been found that the novel use of alkylbenzoic acids provides desirable properties in terms of sun protection while providing a sensory improved galenical form.

[0012] Furthermore, the compositions developed by the applicant are characterized by very good results in in vitro ocular tolerability tests, in contrast to the majority of suncare products currently on the market, a significant advantage since suncare compositions often come into contact with the user's eyes after sweating or swimming.

[0013] Thus, according to a first aspect, the present invention provides a cosmetic or dermatological composition in emulsion form, comprising: (a) a lipid-soluble photoprotective system, (i) hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate, (ii) 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine, (iii) butyl methoxydibenzoylmethane, (iv) ethylhexyltriazone, and (v) diethylhexylbutamidotriazone, a lipid-soluble photoprotective system consisting of one or more lipid-soluble UV filters selected from: (b)C 12 -C 15 alkyl benzoates; and (c) one or more organic particulate UV filters, in particular aqueous dispersions, (vi) 5,6,5',6'-tetraphenyl-3,3'-(1,4-phenylene)-bis[1,2,4]triazine, (vii) methylenebis-benzotriazolyltetramethylbutylphenol, and (viii) tris-biphenyltriazine, Filters to be selected from , including; the lipophilic photoprotective system (a) is present in an amount of from 3 wt% to 19 wt%, in particular from 5 wt% to 19 wt%, in particular from 7 wt% to 17 wt%, generally from 9 wt% to 15 wt%, for example from 10 wt% to 13 wt%, relative to the total weight of the composition; and -C 12 -C 15 The alkyl benzoate (b) is present in an amount of 15 wt% to 30 wt%, in particular 20 wt% to 30 wt%, and generally 20 wt% to 25 wt%, relative to the total weight of the composition; It is characterized by: The composition is characterized in that it does not contain ethylhexyl salicylate, octocrylene, ethylhexyl methoxycinnamate, isoamyl methoxyl cinnamate, homosalate, para-aminobenzoic acid (PABA), octyl dimethyl PABA, 3-methylbenzylidene camphor, 4-methylbenzylidene camphor, benzophenone-3 and / or benzophenone-4.

[0014] According to a second aspect, the present invention provides a cosmetic or dermatological composition in emulsion form, comprising: (a) a lipid-soluble photoprotective system comprising one or more lipid-soluble UV filters selected from filters (i) to (v); (b) a solubilization system of the lipid-soluble photoprotective system (a), 12 -C 15 a solubilizing system comprising alkyl benzoates in an amount of 80 wt% or more, preferably 90 wt% or more, based on the total weight of the solubilizing system; and (c) one or more organic particulate UV filters, in particular aqueous dispersions, selected from filters (vi) to (viii), Includes; the lipid-soluble photoprotective system (a) is present in an amount ranging from 3 wt% to 19 wt%, preferably from 5 wt% to 15 wt%, relative to the total weight of the composition; and the solubilizing system (b) is present in an amount of 15 wt% to 30 wt% relative to the total weight of the composition, It is characterized by: The composition is characterized by not containing ethylhexyl salicylate, octocrylene, ethylhexyl methoxycinnamate, isoamyl methoxyl cinnamate, homosalate, para-aminobenzoic acid (PABA), octyl dimethyl PABA, 3-methylbenzylidene camphor, 4-methylbenzylidene camphor, benzophenone-3 and / or benzophenone-4.

[0015] Detailed Description For the purposes of the present invention, "emulsion" means any type of emulsion obtained by dispersing a discontinuous internal phase in a continuous external phase, one of which is an aqueous phase and the other an oily phase, such as an oil-in-water or water-in-oil or multiple emulsion, preferably an oil-in-water emulsion.

[0016] These emulsions may be more or less fluid and in particular may be in the form of white or colored creams, ointments, milks, lotions, serums, pastes or, optionally, aerosols, foams or sprays, and may also be water-resistant.

[0017] The compositions according to the invention are intended in particular for topical application to the skin and / or hair.

[0018] For the purposes of the present invention, a "photoprotection system" means a combination of compounds which, after application to a surface (skin, hair, etc.), is able to prevent or at least limit UVA and / or UVB radiation from reaching said surface by the mechanisms of absorption and / or reflection and / or diffusion of said radiation. The compounds that make up a photoprotection system are called sun filters or UV filters.

[0019] The term "ultraviolet radiation" or "UV radiation," commonly abbreviated as "UV," refers not only to solar ultraviolet radiation, but also to artificial ultraviolet radiation such as that produced by tanning lamps.

[0020] The term "UVA radiation" or simply "UVA" refers to ultraviolet radiation having a wavelength between 320 and 400 nm.

[0021] The term "UVB radiation" or simply "UVB" refers to ultraviolet radiation having a wavelength between 290 and 320 nm.

[0022] The term "sun filter" or "UV filter" refers to a substance capable of filtering UV radiation in order to protect surfaces, generally skin or hair, from the harmful effects of UV radiation.

[0023] Sun filters qualify as "UVA filters" or "UVB filters" depending on whether they primarily filter UVA or UVB rays.

[0024] Sun filters called "broadband" or "broad spectrum" filter both UVA and UVB rays.

[0025] According to the mechanism of radiation filtering, in other words, whether radiation is absorbed and / or reflected or scattered by the sun filter, a completely strict distinction can be made: - Filters in the strict sense, which primarily absorb radiation, and - Screen that absorbs and reflects radiation.

[0026] However, in the remainder of the description, the term "sun filter", often abbreviated to "filter", will be used interchangeably with filter or screen.

[0027] Sun filters can be "lipid-soluble" or "water-soluble", depending on whether they are more easily solubilized in lipids or water, or they can also be "water-insoluble". Insoluble sun filters are generally particulate, but can nevertheless be incorporated into sun protection compositions in dispersed form, especially aqueous dispersions, when dispersed in the aqueous phase.

[0028] The fat-soluble photoprotection system (a) constituting the composition according to the present invention comprises only fat-soluble sun filters and is contained in an amount of 3 wt% to 19 wt%, preferably 5 wt% to 15 wt%, relative to the total weight of the composition.

[0029] In a particular embodiment, the lipophilic photoprotective system represents from 3 wt% to 19 wt%, in particular from 5 wt% to 19 wt%, in particular from 7 wt% to 17 wt%, typically from 9 wt% to 15 wt%, for example from 10 wt% to 13 wt%, relative to the total weight of the composition.

[0030] The lipophilic photoprotective system constituting the composition according to the invention consists of one or more lipophilic UV filters selected from the filters (i) to (v): (i) Hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate (CAS number: 302776-68-7) (also known as diethylaminohydroxybenzoylhexylbenzoate or DHHB, sold by BASF under the name Uvinul A Plus®)

[0031] It is a lipid-soluble UVA filter with a maximum absorption wavelength λmax equal to 354 nm.

[0032] In certain embodiments, DHHB is comprised between 1 wt% and 10 wt%, for example between 3 wt% and 10 wt%, in particular between 4 wt% and 9 wt%, typically between 5 wt% and 8 wt%, in particular between 5 wt% and 7 wt%, in particular between 6 wt% and 7 wt%, or advantageously between 5 wt% and 6 wt%, relative to the total weight of the composition.

[0033] (ii) 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine (CAS number: 187393-00-6) (also known as bis-ethylhexyloxyphenol methoxyphenyl triazine or BEMT, sold by BASF under the name Tinosorb S®)

[0034] This is a broadband lipophilic filter with two absorption peaks between 310 nm and 340 nm.

[0035] In certain embodiments, BEMT is present in an amount of from 1 wt% to 4 wt%, particularly from 2 wt% to 4 wt%, and especially from 2 wt% to 3 wt%, relative to the total weight of the composition.

[0036] (iii) 4-tert-butyl-4-methoxydibenzoylmethane or butyl methoxydibenzoylmethane (chemical name: 1,4-(1,1-dimethylethyl)phenyl-3-(4-methoxyphenyl)-1,3-propanedione; CAS number: 70356-09-1) (also known as avobenzone or BMDBM, sold in particular under the name Parsol 1789® by DSM)

[0037] This corresponds to a maximum absorption wavelength λ equal to 357 nm. max It is a fat-soluble UVA filter with

[0038] In certain embodiments, the BMDBM is present in an amount of from 1 wt% to 10 wt%, such as from 1 wt% to 8 wt%, particularly from 1 wt% to 5 wt%, typically from 2 wt% to 4 wt%, relative to the total weight of the composition.

[0039] (iv) Ethylhexyl triazone or EHT (chemical name: 4-[[4,6-bis[[4-(2-ethylhexoxy-oxomethyl)phenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid 2-ethylhexyl ester; CAS number: 88122-99-00) (sold by BASF under the name Uvinul T 150®)

[0040] This corresponds to a maximum absorption wavelength λ equal to 314 nm. max It is a fat-soluble UVB filter with

[0041] In certain embodiments, EHT is present in an amount of 1 wt% to 6 wt%, typically 2 wt% to 5 wt%, particularly 3 wt% to 5 wt%, and especially 3.5 wt% to 4.5 wt%, relative to the total weight of the composition.

[0042] (v) Diethylhexylbutamidotriazone or DBT (chemical name: 4,4'-[[6-[[4-[[(1,1-dimethylethyl)amino]carbonyl]phenyl]amino]-1,3,5-triazine-2,4-diyl]diimino]bis-, bis(2-ethylhexyl)benzoate; CAS number: 154702-15-5) (sold under the name Uvasorb HEB® by 3V Sigma)

[0043] This corresponds to a maximum absorption wavelength λ equal to 310 nm. max It is a fat-soluble UVB filter with

[0044] In certain embodiments, DBT is present in an amount of 1 wt% to 6 wt%, typically 2 wt% to 5 wt%, particularly 3 wt% to 5 wt%, and especially 3.5 wt% to 4.5 wt%, relative to the total weight of the composition.

[0045] The lipid-soluble photoprotective system (a) may consist of a single lipid-soluble filter selected from filters (i) to (v).

[0046] Preferably, however, it consists of a combination of at least two lipophilic filters, the first of which is selected from filters (i) to (iii) and the second of which is selected from filters (iv) and (v), the second being in particular filter (iv).In particular, the lipophilic photoprotection system (a) consists of a combination of three filters, the first of which is selected from filters (i) or (iii), the second of which is selected from filters (iv) and (v), the third of which corresponds to filter (ii), and the second of which is advantageously filter (iv).

[0047] In certain embodiments, the lipid-soluble photoprotective system (a) may consist of a combination of the following lipid-soluble filters: (a1) Hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate, 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine and ethylhexyl triazone; (a2) hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate, 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine and diethylhexylbutamidotriazone; (a3) 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine and ethylhexyltriazone; (a4) 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine and diethylhexylbutamidotriazone; (a5) Hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate, butyl methoxydibenzoylmethane, 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine and ethylhexyl triazone; (a6) Hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate, butyl methoxydibenzoylmethane, 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine and diethylhexylbutamidotriazone; (a7) butyl methoxydibenzoylmethane, 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine and ethylhexyl triazone; and (a8) Butyl methoxydibenzoylmethane, 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine and diethylhexylbutamidotriazone. In particular, the lipophilic photoprotective system (a) consists of one of the combinations (a1), (a3), (a5) or (a7).

[0048] When the fat-soluble photoprotective system (a) corresponds to one of the fat-soluble filter combinations (a1) to (a8), it is contained in an amount of 3 wt% to 19 wt%, preferably 5 wt% to 15 wt%, based on the total weight of the composition.

[0049] In a particular embodiment, the lipophilic photoprotective system corresponds to one of the lipophilic filter combinations (a1) to (a8) and represents from 3 wt% to 19 wt%, in particular from 5 wt% to 19 wt%, in particular from 7 wt% to 17 wt%, typically from 9 wt% to 15 wt%, for example from 10 wt% to 13 wt% of the composition relative to the total weight of the composition.

[0050] In particular, the lipophilic photoprotective system (a) consists of the combination (a1) or (a2).

[0051] In this particular embodiment, DHHB is present in an amount of 1 wt% to 10 wt%, for example 3 wt% to 10 wt%, in particular 4 wt% to 9 wt%, generally 5 wt% to 8 wt%, for example 5 wt% to 7 wt%, in particular 6 wt% to 7 wt%, or advantageously 5 wt% to 6 wt%, relative to the total weight of the composition; BEMT is present in an amount of 1 wt% to 4 wt%, in particular 2 wt% to 4 wt%, in particular 2 wt% to 3 wt% of the composition relative to the total weight of the composition; and EHT or DBT is present in an amount of 1 wt% to 6 wt%, generally 2 wt% to 5 wt%, in particular 3 wt% to 5 wt%, in particular 3.5 wt% to 4.5 wt% relative to the total weight of the composition.

[0052] In an advantageous embodiment, the lipophilic photoprotective system (a) consists of a combination of lipophilic filters (a1).

[0053] The lipid-soluble photoprotective system (a) is solubilized in the solubilizing system (b).

[0054] For the purposes of the present invention, the term "solubilizing system", which is understood as solubilizing a lipophilic photoprotection system (a) as defined above, denotes a liquid lipophilic compound or a combination of liquid lipophilic compounds, generally a liquid lipophilic emollient or a combination of liquid lipophilic emollients, in particular a liquid fatty substance or a combination of liquid fatty substances, which is able to completely solubilize one or more lipophilic UV filters (i) to (v) and thus make it possible to obtain a clear homogeneous solution, in which the lipophilic UV filter(s) (i) to (v) are solubilized in an amount or content such that the weight ratio lipophilic UV filter(s) (i) to (v) / solubilizing system is 0.2 or more, generally at least 0.3, preferably at least 0.4 and in particular less than 0.7, in particular 0.6 or less.

[0055] The term "lipophilic liquid compound" means a compound that has an affinity for non-polar substances such as lipids and that is in liquid form, especially at temperatures between 5°C and ambient temperature.

[0056] For the purposes of the present invention, "ambient temperature" means a temperature between 15°C and 25°C, preferably between 20°C and 25°C.

[0057] The term "homogeneous solution" means that there are no crystals and / or aggregates visible to the naked eye in the solution.

[0058] The term "clear solution" means a clear solution, in other words a solution that is not cloudy. The ability to solubilize one or more of the lipophilic UV filters (i) to (v) is evaluated in two stages.

[0059] In a first step, one or more liposoluble UV filters (i) to (v) are solubilized by introducing them into the solubilizing system (b) with stirring at the preparation temperature of the oil phase of the emulsion according to the invention, generally 80°C.

[0060] A clear, homogeneous solution should be obtained in less than 5 hours, in particular less than 4 hours, in particular less than 2 hours, preferably less than 1 hour. The homogeneous, clear solution thus obtained is then cooled, with or without stirring, to ambient temperature or to 5°C.

[0061] After solubilization carried out under the above-mentioned conditions, the solubilization system according to the invention generally makes it possible to maintain one or more liposoluble UV filters (i) to (v) in solubilized form, in other words it also prevents partial recrystallization of one or more liposoluble UV filters (i) to (v).

[0062] Thus, once a homogeneous solution is obtained by solubilization of one or more lipophilic UV filters (i) to (v) in the solubilization system (b), it remains homogeneous and clear, with or without stirring, at a temperature of 5°C and at ambient temperature for at least 24 hours, preferably at least one week, in particular at least one month.

[0063] In a preferred embodiment, the solution obtained by solubilization of one or more liposoluble UV filters (i) to (v) in the solubilization system (b) remains homogeneous and clear, with or without stirring, at ambient temperature, advantageously at a temperature of 5° C., for at least 6 months, preferably at least 12 months, in particular at least 24 months, in particular at least 36 months.

[0064] The solubilization system (b) according to the present invention is 12 -C 15 The alkyl benzoate is contained in an amount of 80 wt% or more, preferably 90 wt% or more, advantageously 95 wt% or more, in particular 98 wt% or more, especially 99 wt% or more, based on the total weight of the solubilizing system.

[0065] According to a particular embodiment, C 12 -C 15 The alkyl benzoate comprises 100 wt % based on the total weight of the solubilizing system. For purposes of this invention, "C12 -C 15 "Alkyl benzoate" refers to a compound having the general formula: C6H5-C(O)OR, where R is (C 12 -C 15 )-alkyl] or a mixture thereof.

[0066] For purposes of this invention, "(C 12 -C 15 ")Alkyl" means a monovalent saturated, straight or branched hydrocarbon chain having 12 to 15 carbon atoms.

[0067] The term “C 12 -C 15 By "alkyl benzoates" is meant in particular the following commercially available products: Cetiol AB® (BASF), Crodamol AB® (Croda), Finsolv TN® (Innospec) and Tegosoft TN® (Evonik).

[0068] As is clear from the above, those skilled in the art will recognize that a composition comprising one or more liquid lipophilic compounds, generally one or more liquid lipophilic emollients, is a composition comprising C as the majority component. 12 -C 15 It can be verified that alkyl benzoates comprise at least 80% by weight, preferably at least 90% by weight, advantageously at least 95% by weight, in particular at least 98% by weight, in particular at least 99% by weight and in particular 100% by weight relative to the total weight of said combination, constitute a solubilizing system within the meaning of the present invention by applying the following protocol: - introducing a lipophilic photoprotective system according to the invention as defined above into a solubilizing system in such a way that the weight ratio lipophilic system / solubilizing system is greater than or equal to 0.2, generally at least equal to 0.3, preferably at least equal to 0.4 and in particular less than 0.7, in particular less than or equal to 0.6; - placing the mixture obtained under stirring, preferably mechanically by means of a magnetic bar, at a temperature between 70°C and 85°C, generally 80°C, and continuing to stir for a period of 5 minutes to 5 hours, in particular 10 minutes to 4 hours, in particular 20 minutes to 2 hours, generally 30 minutes to 1 hour; - Observe that a homogeneous, clear solution is obtained, in other words, that there is no turbidity and no crystals and / or aggregates visible to the naked eye in the solution; cooling the homogeneous solution, with or without stirring, to ambient temperature, that is to say to a temperature generally between 15°C and 25°C, preferably between 20°C and 25°C; - leaving the solution undisturbed for at least 24 hours, in particular for at least one week up to three months, and generally for one month; and -Maintaining the homogeneity of the solution, in other words observing the absence of crystals and / or aggregates visible to the naked eye in the solution.

[0069] Alternatively, after obtaining a homogeneous, clear solution, the solution can be cooled to about 5°C, typically 5°C, and allowed to stand without stirring for at least 24 hours, particularly at least 1 week to 1 month, to observe whether the solution maintains its homogeneity.

[0070] C to form the solubilized system according to the present invention 12 -C 15 The one or more liquid lipophilic compounds that can be combined with the alkyl benzoates generally comprise one or more polar chemical functional groups selected from the following functional groups: ester (-CO2-), alcohol (-OH), ether (-O-), carbonate (-OCO2-) and carboxylic acid (-CO2H), and one or more lipophilic groups, i.e. one or more aliphatic and / or aromatic hydrocarbon groups, in particular one or more saturated or unsaturated, linear or branched hydrocarbon chains having from 6 to 20 carbon atoms, for example from 7 to 18 carbon atoms, in particular from 8 to 16 carbon atoms, phenyl groups (-CH5) and / or phenylalkyl groups.

[0071] In certain embodiments, to form a solubilized system according to the present invention, 12 -C 15 The one or more lipophilic compounds, in particular the one or more liquid lipophilic emollients, which may be combined with the alkyl benzoate include caprylic / capric triglyceride, dicaprylyl carbonate, coco caprylate, diisopropyl sebacate, diethylhexyl succinate, isopropyl palmitate, isopropyl myristate, propylheptyl caprylate, phenethyl benzoate, dibutyl adipate, diisopropyl adipate, glyceryl tri-2-ethylhexanoate, pentaerythrityl tetra-2-ethylhexanoate, cetyl 2-ethylhexanoate, isononyl isononanoate, butylene glycol dicaprylate / dicaprate, octyldodecanol, propylene glycol dicaprylate / dicaprate and dicaprylic acid. and in particular caprylic / capric triglyceride, dicaprylyl carbonate, isopropyl palmitate, propylheptyl caprylate, phenethyl benzoate, diisopropyl adipate, glyceryl tri-2-ethylhexanoate, pentaerythrityl tetra-2-ethylhexanoate, cetyl 2-ethylhexanoate, isononyl isononanoate, butylene glycol dicaprylate / dicaprate, octyldodecanol, propylene glycol dicaprylate / dicaprate and dicaprylyl ether.

[0072] In a particular embodiment, the solubilization system (b) is present in an amount of 80 wt% or more, preferably 90 wt% or more, advantageously equal to 95 wt% or more, particularly 98 wt% or more, particularly 99 wt% or more, in particular 100 wt% based on the total weight of the solubilization system. 12 -C 15 alkyl benzoates, caprylic / capric triglycerides and dicaprylyl carbonate, preferably C 12 -C 15Alkyl Benzoate and Caprylic / Capric Triglyceride, C 12 -C 15 It is composed of one or more liquid lipophilic emollients selected from alkyl benzoates.

[0073] The solubilizing system (b) represents from 15 wt% to 30 wt%, in particular from 20 wt% to 30 wt%, typically from 20 wt% to 25 wt%, relative to the total weight of the composition.

[0074] In particular, C 12 -C 15 The alkyl benzoate is present in an amount of from 15 wt% to 30 wt%, in particular from 20 wt% to 30 wt%, and generally from 20 wt% to 25 wt%, relative to the total weight of the composition.

[0075] In a particular embodiment of the composition according to the invention, the lipophilic photoprotective system (a) is as defined above and the weight ratio lipophilic photoprotective system (a) / solubilizing system (b) is greater than or equal to 0.2, generally greater than or equal to 0.3, in particular greater than or equal to 0.4, advantageously greater than or equal to 0.5, in particular definitely greater than 0.5 and less than 0.7, generally less than or equal to 0.6, in particular less than or equal to 0.55.

[0076] In particular, the lipid-soluble photoprotective system (a) is as described above, and the lipid-soluble photoprotective system (a) / C 12 -C 15 The weight ratio of alkyl benzoate is 0.2 or more, generally 0.3 or more, in particular 0.4 or more, advantageously 0.5 or more, in particular definitely more than 0.5 and less than 0.7, generally 0.6 or less, in particular 0.55 or less.

[0077] The lipophilic photoprotective system (a) represents from 3 wt% to 19 wt%, in particular from 5 wt% to 19 wt%, in particular from 7 wt% to 17 wt%, typically from 9 wt% to 15 wt%, for example from 10 wt% to 13 wt% of the composition relative to the total weight of the composition, and in particular consists of one of the combinations (a1) to (a8), in particular one of the combinations (a1), (a3), (a5) or (a7), advantageously combination (a1).

[0078] The solubilizing system (b) is in particular present in an amount of 15 wt% to 30 wt%, in particular 20 wt% to 30 wt%, generally 20 wt% to 25 wt%, relative to the total weight of the composition, and is present in an amount of 80 wt% or more, preferably 90 wt% or more, advantageously 95 wt% or more, in particular 98 wt% or more, in particular 99 wt% or more, in particular 100 wt% relative to the total weight of the solubilizing system; C 12 -C 15 alkyl benzoates, caprylic / capric triglycerides and dicaprylyl carbonate, preferably C 12 -C 15 Alkyl Benzoate and Caprylic / Capric Triglyceride, C 12 -C 15 It is composed of one or more liquid lipophilic emollients selected from alkyl benzoates.

[0079] In certain embodiments, the compositions according to the present invention do not contain diisopropyl sebacate, diethylhexyl succinate, isopropyl myristate and / or dibutyl adipate.

[0080] In another particular embodiment, the composition according to the invention does not comprise dicaprylyl carbonate, coco caprylate, diisopropyl sebacate, diethylhexyl succinate, isopropyl palmitate, isopropyl myristate, propyl heptyl caprylate, phenethyl benzoate, dibutyl adipate, diisopropyl adipate, glyceryl tri-2-ethylhexanoate, pentaerythrityl tetra-2-ethylhexanoate, cetyl 2-ethylhexanoate, isononyl isononanoate, butylene glycol, dicaprylate / dicaprate, octyldodecanol, propylene glycol dicaprylate / dicaprate and / or dicaprylyl ether.

[0081] The composition according to the invention further comprises (c) one or more, in particular aqueous-dispersed particulate organic UV filters, selected from the following filters (vi) to (viii):

[0082] (vi) 5,6,5',6'-tetraphenyl-3,3'-(1,4-phenylene)-bis[1,2,4]triazine (CAS number: 55514-22-2) (also known as phenylenebis-diphenyltriazine)

[0083] This is mainly due to the maximum absorption wavelength λ equal to 355 nm. max It is a non-soluble UVA filter having

[0084] The phenylenebis-diphenyltriazine is generally in the form of an aqueous dispersion and comprises from 20 wt % to 50 wt %, in particular from 40 wt % to 50 wt %, of active substance relative to the total weight of the dispersion.

[0085] Advantageously, the method for preparing the aqueous dispersion comprises grinding the insoluble organic filler into particulate form using a grinding device in the presence of a grinding aid.

[0086] Conventionally, wet milling methods (wet grinding, wet mixing) are used, and grinding aids allow for better particle dispersion. These techniques are well known to those skilled in the art.

[0087] The grinding device can be, for example, a microbead mill, a vibrating mill, or a ball mill.

[0088] Depending on the grinding method, grinding aids are selected from the group consisting of anionic, nonionic or amphoteric surfactants, emulsifiers and dispersants, such as PPG-1-PEG-9 lauryl glycol ether (Eumulgin® L, sold by BASF).

[0089] In a particular embodiment, the phenylene bis-diphenyl triazine is present in an amount of from 1 wt% to 5 wt%, particularly from 2 wt% to 5 wt%, especially from 2 wt% to 4 wt%, typically from 3 wt% to 4 wt%, relative to the total weight of the composition. It is understood that these weight percentages, like all weight percentages set forth herein, are expressed as a percentage by weight of active material relative to the total weight of the composition.

[0090] In certain embodiments, the particle size D of the phenylene bis-diphenyl triazine 50 is 100 to 1000 nm, more specifically 100 to 500 nm, even more specifically 120 to 400 nm, particularly 120 to 250 nm, especially 120 to 200 nm, and generally 150 to 200 nm.

[0091] The term “D 50 "Size" or "median" shall mean the size at which the cumulative function F(D) is equal to 50 wt%, where F(D) is defined according to the following formula:

number

[0092] D 50 The value of is measured according to the method described in the Examples section of this specification.

[0093] (vii) methylene bis-benzotriazolyl tetramethylbutylphenol (chemical name: 2,2'-methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol; CAS number: 103597-45-1) (also known as MBBT, sold by BASF under the name Tinosorb M®)

[0094] This is a non-soluble broadband filter with two absorption peaks at 306 nm and 348 nm.

[0095] MBBT is generally present in the form of an aqueous dispersion and contains 40% to 60% by weight, generally 50% by weight, of the active substance relative to the dispersion.

[0096] According to a particular embodiment, MBBT is present in an amount of 1 wt% to 7 wt%, typically 2 wt% to 6 wt%, particularly 2 wt% to 5 wt%, and especially 3 wt% to 4 wt%, relative to the total weight of the composition.

[0097] In certain embodiments, the particle size D of MBBT 50 is 50 nm to 250 nm, particularly 60 nm to 150 nm.

[0098] (viii) 2,4,6-tris(biphenyl-4-yl)-1,3,5-triazine (CAS number: 31274-51-8) (also known as tris-biphenyltriazine or TBPT, sold by BASF under the name Tinosorb A2B®)

[0099] This is mainly due to the maximum absorption wavelength λ equal to 310 nm. max It is a non-soluble UVB filter having

[0100] TBPT is generally in the form of an aqueous dispersion and contains 40 wt% to 60 wt%, generally 50 wt%, of the active material based on the dispersion.

[0101] In certain embodiments, TBPT is present in an amount of from 1 wt% to 7 wt%, particularly from 2 wt% to 7 wt%, and especially from 2 wt% to 6 wt%, based on the total weight of the composition.

[0102] In certain embodiments, the particle size D of TBPT 50 is 50 nm to 250 nm, particularly 80 nm to 150 nm.

[0103] In a particular embodiment of the composition according to the invention, the one or more, in particular aqueous dispersed particulate organic UV filters are selected from phenylenebis-diphenyltriazines (vi) to MBBT (vii).

[0104] Advantageously, the composition according to the invention comprises a single particulate organic UV filter, preferably phenylenebis-diphenyltriazine.

[0105] According to a particular embodiment of the composition according to the invention, the weight ratio of particulate organic UV filter (c) / lipid-soluble photoprotective system (a) is less than or equal to 0.35, in particular less than or equal to 0.33, advantageously less than or equal to 0.32, in particular less than or equal to 0.30 and in particular greater than or equal to 0.2.

[0106] According to a particular embodiment, the cosmetic or dermatological composition according to the invention comprises: (a) a lipid-soluble photoprotective system comprising one or more lipid-soluble UV filters selected from filters (i) to (v); (b) a solubilization system of the lipid-soluble photoprotective system (a), 12 -C 15 a solubilizing system comprising alkyl benzoates in an amount of 80 wt. % or more, preferably 90 wt. % or more, based on the total weight of the solubilizing system; and (c) phenylenebis-diphenyltriazine as an aqueous dispersed particulate organic UV filter (advantageously in an amount of 1 wt % to 5 wt %, in particular 2 wt % to 5 wt %, in particular 2 wt % to 4 wt %, typically 3 wt % to 4 wt %, relative to the total weight of the composition), the lipophilic photoprotective system (a) represents from 3 wt% to 19 wt%, in particular from 5 wt% to 19 wt%, in particular from 7 wt% to 17 wt%, generally from 9 wt% to 15 wt%, for example from 10 wt% to 13 wt% of the composition relative to the total weight of the composition; and the solubilizing system (b) is present in an amount of 15 wt% to 30 wt% relative to the total weight of the composition, It is characterized by Has been; The composition is characterized by being free of ethylhexyl salicylate, octocrylene, ethylhexyl methoxycinnamate, isoamyl methoxyl cinnamate, homosalate, para-aminobenzoic acid (PABA), octyl dimethyl PABA, 3-methylbenzylidene camphor, 4-methylbenzylidene camphor, benzophenone-3 and / or benzophenone-4.

[0107] In this particular embodiment, the lipid-soluble photoprotective system (a) and its solubilizing system (b) are as described above, as is the weight ratio (a) / (b).

[0108] Advantageously, the weight ratio of phenylenebis-diphenyltriazine (c) / lipid-soluble photoprotective system (a) is less than or equal to 0.35, in particular less than or equal to 0.33, advantageously less than or equal to 0.32, in particular less than or equal to 0.30 and greater than or equal to 0.2.

[0109] Advantageously, the weight ratio of phenylenebis-diphenyltriazine (c) / lipid-soluble photoprotective system (a) is 0.35 or less, in particular 0.33 or less, advantageously 0.32 or less, in particular 0.30 or less and in particular 0.2 or more, and the weight ratio of the lipophilic photoprotective system (a) / C 12 -C 15 The weight ratio of alkyl benzoate is 0.2 or more, generally 0.3 or more, in particular 0.4 or more, advantageously 0.5 or more, in particular definitely more than 0.5 and in particular less than 0.7, generally 0.6 or less, in particular 0.55 or less.

[0110] In a particular embodiment, the lipophilic photoprotective system (a) corresponds to one of the lipophilic filter combinations (a1) to (a8) and represents from 3 wt% to 19 wt%, in particular from 5 wt% to 19 wt%, in particular from 7 wt% to 17 wt%, typically from 9 wt% to 15 wt%, for example from 10 wt% to 13 wt% of the composition relative to the total weight of the composition.

[0111] In particular, the lipophilic photoprotective system (a) consists of the combination (a1).

[0112] In this particular embodiment, DHHB is present in an amount of 1 wt% to 10 wt%, for example 3 wt% to 10 wt%, in particular 4 wt% to 9 wt%, typically 5 wt% to 8 wt%, for example 5 wt% to 7 wt%, in particular 6 wt% to 7 wt%, or advantageously 5 wt% to 6 wt%, relative to the total weight of the composition; BEMT is present in an amount of 1 wt% to 4 wt%, in particular 2 wt% to 4 wt%, in particular 2 wt% to 3 wt% of the composition relative to the total weight of the composition; and EHT is present in an amount of 1 wt% to 6 wt%, typically 2 wt% to 5 wt%, in particular 3 wt% to 5 wt%, in particular 3.5 wt% to 4.5 wt%, relative to the total weight of the composition.

[0113] In certain embodiments, the compositions according to the present invention do not contain diisopropyl sebacate, diethylhexyl succinate, isopropyl myristate and / or dibutyl adipate.

[0114] In another specific embodiment, the compositions of the present invention do not contain dicaprylyl carbonate, coco caprylate, diisopropyl sebacate, diethylhexyl succinate, isopropyl palmitate, isopropyl myristate, propyl heptyl caprylate, phenethyl benzoate, dibutyl adipate, diisopropyl adipate, glyceryl tri-2-ethylhexanoate, pentaerythrityl tetra-2-ethylhexanoate, cetyl 2-ethylhexanoate, isononyl isononanoate, butylene glycol dicaprylate / dicaprate, octyldodecanol, propylene glycol dicaprylate / dicaprate and / or dicaprylyl ether.

[0115] In certain embodiments, the composition according to the present invention does not include a water-soluble filter.

[0116] The absence of water-soluble filters in the compositions according to the invention is particularly advantageous in that water-soluble filters are generally more easily assimilated by marine organisms than fat-soluble or non-water-soluble filters. As a result, the applicant's choice of using only fat-soluble filters or, in particular, particulate filters that are aqueous-dispersed, allows the impact of the compositions according to the invention on the marine environment to be minimized.

[0117] In certain embodiments, the compositions according to the present invention comprise one or more particulate inorganic fillers, such as titanium dioxide (TiO2) or zinc oxide (ZnO).

[0118] The one or more particulate inorganic fillers optionally present in the composition according to the invention generally have a particle size D between 15 nm and 150 nm. 50 It has.

[0119] In another particular embodiment, the composition according to the invention does not contain a particulate inorganic filter.

[0120] In certain embodiments, the total number of UV filters present in the composition is 5 or less, preferably 4 or less, and all UV filters present in the composition comprise from 4 wt% to 25 wt%, in particular from 6 wt% to 20 wt%, in particular from 7 wt% to 18 wt%, typically from 8 wt% to 17 wt%, relative to the total weight of the composition.

[0121] Advantageously, the compositions according to the invention are photostable.

[0122] For the purposes of the present invention, "photostable" means that at least 80%, preferably at least 85%, advantageously at least 90% of the total SPF is preserved after 5 MED, preferably 10 MED of irradiation.

[0123] The term "SPF" stands for sun protection factor and is rated as a total SPF for wavelengths between 290 and 400 nm.

[0124] The value is determined according to the method recommended in the guidelines published in March 2011 by COLIPA (European trade association for cosmetic and personal care industry) and described in the Examples section of this specification.

[0125] In a particular embodiment, the compositions according to the invention have an SPF of 50 or more, advantageously 60 or more.

[0126] In another particular embodiment, in accordance with the regulations in force, the SPF / UVA ratio is less than or equal to 3. The denominator of the quotient corresponds to the UVA portion of the total SPF (320-400 nm) and can be calculated according to the method recommended by COLIPA (European trade association for cosmetic and personal care industry) in the guidelines published in March 2011. Advantageously, the SPF / UVA ratio is less than or equal to 2.5.

[0127] The compositions according to the invention may further comprise one or more cosmetically or dermatologically acceptable excipients.

[0128] In the present invention, the term "cosmetically or dermatologically acceptable" means something that can be used in the preparation of a cosmetic or dermatological composition, is generally safe, non-toxic, not biologically or otherwise undesirable, and is acceptable for human cosmetic or dermatological use.

[0129] The term "cosmetically or dermatologically acceptable excipient" means a cosmetically or dermatologically acceptable adjuvant that allows the preparation, storage or administration of the composition.

[0130] Thus, the compositions according to the invention may comprise conventional pharmaceutical or dermatological adjuvants chosen in particular from emulsifiers, consistency agents, humectants, texturizing agents, opacifiers, color pigments, antifoaming agents, fragrances, preservatives, polymers, fillers, sequestering agents, bactericides, odor absorbers, alkalizing or acidifying agents, surfactants, free radical scavengers, vitamins E and C, alpha hydroxy acids, active agents (in particular emollients, moisturizers, antioxidants), or other ingredients usually used in the manufacture of sun protection compositions.

[0131] The composition may further comprise a polyol miscible with water at ambient temperature (about 25°C), in particular a polyol having 2 to 20 carbon atoms, preferably 2 to 10 carbon atoms, more preferably 2 to 6 carbon atoms, such as glycerin; glycol derivatives such as propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, dipropylene glycol, diethylene glycol; glycol ethers such as C1-C4 alkyl ethers of mono-, di- or tri-propylene glycol, C1-C4 alkyl ethers of mono-, di- or tri-ethylene glycol, and mixtures thereof.

[0132] The compositions may also contain derivatives of glucose, such as cetearyl glucoside, arachidyl glucoside, lauryl glucoside, polyglyceryl-3 methyl glucose distearate and methyl glucose sesquistearate; sucrose derivatives, such as sucrose polystearate and sucrose palmitate; fatty acid glycerides, such as glyceryl stearate, glyceryl oleate and glyceryl stearate citrate; glutamic acid derivatives, such as sodium stearoyl glutamate; sulfosuccinic acid derivatives, such as disodium cetearyl sulfosuccinate and sodium dioctyl sulfosuccinate; phosphoric acid derivatives, such as potassium cetyl phosphate; polyglyceryl fatty acid esters, such as poly The emulsifiers may include one or more anionic, cationic, and nonionic emulsifiers selected from glyceryl-3-diisostearate and polyglyceryl-2-dipolyhydroxystearate; sorbitol derivatives such as polysorbate-n, PEG-10 sorbitan laurate, and sorbitan esters; fatty alcohol and fatty acid polyglycol ethers such as ceteareth-20, beheneth-25, steareth-2, trideceth-9, PEG-5 ethylhexanoate, and PEG-100 stearate; sodium lauryl sulfate, sodium stearate, and organo-modified oxyalkenylated silicone / polysiloxane / polyalkyl / polyether copolymers and derivatives.

[0133] In certain embodiments, the one or more emulsifiers comprise from 1 wt% to 5 wt%, preferably from 1 wt% to 3 wt%, based on the total weight of the composition.

[0134] In a particular embodiment, the composition according to the invention comprises one or more emulsifiers selected from potassium cetyl phosphate, lauryl glucoside and glyceryl stearate citrate.

[0135] In certain embodiments, the composition according to the present invention does not comprise an ethoxylated emulsifier and / or an emulsifier comprising a PEG chain.

[0136] In particular, the composition does not contain sorbitol derivatives, such as polysorbate-n and PEG-10 sorbitan laurate; fatty alcohol and fatty acid polyglycol ethers, such as ceteareth-20, beheneth-25, steareth-2 and PEG-100 stearate; and organo-modified oxyalkenylated silicone / polysiloxane / polyalkyl / polyether copolymers and derivatives.

[0137] The compositions may also contain fatty alcohols such as cetyl alcohol, cetearyl alcohol and stearyl alcohol; fatty acids such as stearic acid; fatty acid esters such as myristyl stearate; polysaccharides or derivatives such as xanthan gum, guar gum, agar gum, alginate, gellan and carrageenan gum; cellulose derivatives such as hydroxypropyl cellulose; waxes such as beeswax, carnauba wax, microcrystalline wax, ceresin, and ozokerite; polyacrylates or acrylic acid or crosslinked polyacrylamide homopolymers such as carbomer, acrylate copolymers, crosslinked acrylate / (C 10 -C 30 ) alkyl acrylate copolymer, behenethyl-25 acrylate / methacrylate; and one or more solid consistency agents selected from silicate derivatives, such as magnesium silicate.

[0138] In certain embodiments, one or more consistency agents are present in an amount of from 0.1 wt% to 2 wt%, preferably from 0.1 wt% to 1 wt%, based on the total weight of the composition.

[0139] In certain embodiments, the compositions according to the invention comprise one or more consistency agents selected from fatty alcohols, such as cetyl alcohol, cetearyl alcohol and stearyl alcohol; fatty acids, such as stearic acid; fatty acid esters, such as myristyl stearate; polysaccharides or derivatives, such as xanthan gum, guar gum, agar gum, alginate, gellan gum and carrageenan gum; cellulose derivatives, such as hydroxypropyl cellulose.

[0140] In a particular embodiment, the composition according to the present invention does not comprise a consistency agent selected from acrylates and their derivatives.

[0141] The composition may also include one or more humectants selected from copolymers of N-vinylpyrrolidone (VP) and eicosene (INCI: VP / eicosene copolymer), crosslinked trimethylpentanediol polymer, adipic acid and glycerol (INCI: trimethylpentanediol / adipic acid / glycerin crosspolymer), polyamide 3 (INCI), copolymers of acrylates and octylacrylamide (INCI: acrylates / octylacrylamide copolymer), and triacontanyl PVP (INCI).

[0142] In certain embodiments, one or more water retention elements are present in an amount of from 0 wt% to 2 wt%, preferably from 0 wt% to 1 wt%, based on the total weight of the composition.

[0143] Preferably, the composition according to the invention comprises a VP / eicosene copolymer as a humectant.

[0144] The composition may also contain one or more texturing agents in powder form, especially chosen from the members of the starch family, such as rice starch, corn starch and tapioca starch; talc and cellulose derivatives, such as microcrystalline cellulose.

[0145] In certain embodiments, the one or more texturizing agents comprise from 1 wt% to 10 wt%, preferably from 1 wt% to 5 wt%, based on the total weight of the composition.

[0146] In certain embodiments, the compositions of the present invention do not contain any texturing agent selected from derivatives of nylon and poly(methyl methacrylate) (PMMA).

[0147] The composition may also contain color pigments chosen in particular from CI 77891, CI 77491, CI 77492 and CI 77499 (INCI names).

[0148] In certain embodiments, the compositions of the present invention comprise C1-C4 alcohols, such as ethanol and isopropanol, in an amount of 4 wt % or less, preferably 2 wt % or less, particularly 1 wt % or less, and in particular 0.5 wt % or less, relative to the total weight of the composition.

[0149] In another particular embodiment, the composition according to the invention does not contain ethanol or isopropanol.

[0150] In a particular embodiment, the composition according to the invention comprises volatile components in an amount of 5 wt. % or less, preferably 2 wt. % or less, in particular 1 wt. % or less, in particular 0.5 wt. % or less, relative to the total weight of the composition.

[0151] For the purposes of the present invention, "volatile components" means non-alcoholic volatile organic or inorganic compounds, such as volatile esters, silicones, alkanes, characterized by a flash point below 60°C.

[0152] For the purposes of this invention, "flash point" (FP) means the lowest temperature at which a pyrophoric substance gives rise to a sufficient concentration of vapor to form a gaseous mixture with the surrounding air that ignites on contact with a flame or hot spot, but is insufficient for combustion to propagate by itself in the absence of a so-called pilot flame. According to Regulation (EC) No 1272 / 2008 on the classification, labelling and packaging of substances and mixtures, substances with an FP of 23°C ≤ FP < 60°C belong to Category 3 "low flammability".

[0153] The volatile ester may include, among others, isohexyl neopentanoate.

[0154] The volatile silicone may include, among others, cyclopentasiloxane.

[0155] The volatile alkane may include, among others, isohexadecane.

[0156] In another particular embodiment, the composition of the invention does not contain any volatile components within the meaning of the present invention.

[0157] The composition may also contain alkalizing or acidifying agents, particularly acids and bases, that can adjust the pH range of the composition. Bases may be inorganic (such as soda, potash, ammonia, etc.) or organic, such as mono-, di-, or triethanolamine, aminomethylpropanediol, N-methyl-glucamine, basic amino acids such as arginine and lysine, and mixtures thereof. Acids may be inorganic (such as hydrochloric acid) or organic, such as lactic acid and citric acid.

[0158] The compositions according to the invention may further comprise additional active agents chosen in particular from hydrating agents, desquamating agents, barrier function improving agents, depigmenting agents, antioxidants, dermocontracting agents, anti-glycation agents, agents stimulating the synthesis of dermal and / or epidermal macromolecules and / or preventing their degradation, agents stimulating fibroblast or keratinocyte proliferation and / or keratinocyte differentiation, NO synthase inhibitors, agents increasing sebaceous gland activity, tensioning agents, lipostructuring agents, slimming agents, agents promoting cutaneous microcirculation, soothing and / or irritating agents, sebum regulating or anti-seborrhoeic agents, astringents, healing agents, anti-inflammatory agents, anti-acne agents, and mixtures thereof.

[0159] In a particular embodiment, the composition according to the present invention does not contain silicone.

[0160] The compositions according to the invention are more particularly sun protection compositions, commonly called sun care compositions, for protecting the skin (face and / or body) and / or hair from ultraviolet radiation.

[0161] Another object of the present invention is a method for protecting the skin (face and / or body) and / or hair from ultraviolet radiation, which method comprises applying to the skin (face and / or body) and / or hair a composition as defined above.

[0162] The present invention further relates to a composition as defined above for use in protecting the skin (face and / or body) and / or hair from ultraviolet radiation.

[0163] The present invention further relates to the use of the composition described above for protecting the skin (face and / or body) and / or hair from ultraviolet radiation.

[0164] The present invention further relates to a method for preparing the composition according to the invention described above in the form of an oil-in-water emulsion, comprising the steps of: - solubilizing one or more lipophilic filter systems in the solubilization system (b) with stirring, preferably with mechanical stirring, at a temperature between 70°C and 85°C, generally 80°C; - adding the other constituents of the oily phase of the emulsion to the mixture obtained above, with stirring, preferably mechanical stirring, at a temperature between 70°C and 85°C, generally 80°C; - dispersing one or more particulate organic fillers (c) in water under stirring, preferably mechanical stirring, at a temperature between 70°C and 85°C, generally 80°C; - adding the other constituents of the aqueous phase of the emulsion to the mixture obtained above, with stirring, preferably mechanical stirring, at a temperature between 70°C and 85°C, generally at a temperature between 80°C; - introducing, with stirring, preferably mechanical stirring, the oily phase previously obtained into the aqueous phase previously obtained, to obtain a homogeneous solution; - cooling the emulsion thus obtained to ambient temperature; and - optionally adding, with stirring, preferably mechanical stirring, a flavoring, an active agent and / or a texturing agent in powder form. [Example]

[0165] The following abbreviations were used: [Table 1]

[0166] I. solubilization system The ability of three combinations of liquid lipophilic emollients, S1, S2 and S3, to solubilize the same lipophilic photoprotection system, here the system (a1) described above, was evaluated according to the following protocol: - solubilizing the lipophilic photoprotection system (a1) in combination with the lipophilic emollient at 80°C with stirring, preferably mechanically with a magnetic bar; -Cool down to ambient temperature; - A sample of the resulting solution is stored at ambient temperature and another sample is cooled to 5°C for similar storage; - Visually inspect the appearance of recrystallization periodically over time.

[0167] The results obtained for the combinations S1, S2 and S3 are reported in the table below, in which the amount of each lipophilic emollient is given as a percentage by weight relative to the total weight of the combination S1, S2 or S3, and the amount of each lipophilic filter is given as a percentage by weight relative to the total weight of the lipophilic photoprotection system (a1).

[0168] [Table 2]

[0169] The solubilization system according to the invention, consisting solely of S1, makes it possible, on the one hand, to solubilize the lipophilic photoprotection system so as to obtain a homogeneous clear solution, and, on the other hand, to prevent the recrystallization of the lipophilic UV filters over time.

[0170] For comparison, the stability of another oil phase of a sunscreen emulsion, corresponding to that of Example B3 of application WO2016 / 012586, was evaluated according to the following protocol: - solubilizing the lipophilic photoprotective system in the solubilizing system at 80°C with mechanical stirring by a magnetic bar; -Cool down to ambient temperature; -Store the resulting solution at room temperature; - Visually inspect the appearance of recrystallization periodically over time.

[0171] [Table 3]

[0172] II. composition In the formula below, 5,6,5',6'-tetraphenyl-3,3'-(1,4-phenylene)-bis[1,2,4]triazine is in the form of an aqueous dispersion containing 45 wt% (wt / wt) of active substance, and has a D of 150-250 nm. 50 It is characterized by:

[0173] II.1. Method for preparing emulsions

[0174] The oil phase ingredients (in particular one or more fat-soluble UV filters, a solubilizing system, one or more emulsifiers, one or more fat-soluble viscosity agents) on the one hand, and the water phase ingredients (in particular one or more particulate organic filters, one or more polyols, one or more water-soluble viscosity agents and water) on the other hand, are mixed and heated to 80°C with stirring.

[0175] The oil phase is then added to the water phase while stirring until homogenous. Finally, the composition thus obtained is cooled to ambient temperature while being stirred.

[0176] Optionally, perfumes, active agents, and one or more texturizing agents in powder form are added with stirring after the final composition has cooled.

[0177] [Table 4]

[0178] The liposoluble photoprotection system advantageously represents between 12% and 14% by weight relative to the total weight of the composition.

[0179] [Table 5]

[0180] The liposoluble photoprotection system advantageously represents between 12% and 14% by weight relative to the total weight of the composition.

[0181] [Table 6]

[0182] [Table 7]

[0183] [Table 8]

[0184] [Table 9]

[0185] [Table 10]

[0186] III. Measurement of particle size of 5,6,5',6'-tetraphenyl-3,3'-(1,4-phenylene)-bis[1,2,4]triazine

[0187] D of phenylenebis-diphenyltriazine particles 50 was measured by the liquid method using a Mastersizer 3000 laser diffraction particle size analyzer.

[0188] A sample of the aqueous dispersion of phenylenebis-diphenyltriazine is placed under magnetic stirring (2500 rpm) for 2 minutes.

[0189] 1 mL of the sample was taken and placed in a flask, which was then filled to 100 mL with ultrapure water.

[0190] The solution thus obtained is placed under magnetic stirring (2500 rpm) for 30 seconds. The solution to be examined is taken and introduced into the measuring vessel up to the 15% obscuration limit.

[0191] Three independent measurements are performed per test (red laser: background noise measurement, 10 seconds, sample measurement, 10 seconds; blue laser: background noise measurement, 10 seconds, sample measurement, 10 seconds).

[0192] The results were given in volume and converted to numbers using software.

[0193] IV. Sun protection rating

[0194] The evaluation of the parameters allowing the quantification of the photoprotection provided by the compositions according to the invention is carried out according to the methods recommended in the COLIPA (European trade association for cosmetic and personal care industry) guidelines published in March 2011.

[0195] IV.1.Equipment

[0196] -UV spectrometer

[0197] The spectrophotometer measures the spectral transmittance through the plate with and without a layer of sunscreen composition thereon.

[0198] The spectrophotometer must be capable of measuring from 290 nm to 400 nm. The area of ​​the reading zone should be at least 0.5 cm to reduce variability between measurements and compensate for lack of uniformity in the product layer. 2 It is recommended to set it to

[0199] The spectrophotometer used for these measurements is a Labsphere® UV-1000S or 2000S.

[0200] -plate

[0201] The plate is the material onto which the sunscreen composition is applied. This material must be UV transparent, non-fluorescent, photostable, and inert to the components of the test composition. In this protocol, a PMMA plate proved ideal.

[0202] -UV source

[0203] The UV source is a solar simulator equipped with a xenon arc lamp that provides visible, UVA, and UVB spectrum. The UV light source used in this study is a Suntest CPS+ (Atlas).

[0204] IV.2. Methods for measuring SPF and photostability

[0205] -Measurement of transmittance of untreated plates

[0206] In a first step, the UV transmittance of a control plate must be measured, which is prepared by sprinkling a few microliters of glycerol onto the plate so that the surface is completely covered.

[0207] -Sample application

[0208] The sample to be tested was 1.3 mg / cm 2 (actual amount remaining on the plate) onto the PMMA plate. To ensure accuracy of the dose and reproducibility of the results, the application area was 10 cm. 2 Let's say it's super.

[0209] The sample to be tested is applied in the form of multiple small drops of equal volume distributed over the surface of the plate.

[0210] A method for checking the amount of product applied must be employed to ensure that the amount of product is adequate (eg, weighing the plate before and after product application).

[0211] After applying the specified amount of sample, the sample must be spread across the entire plate as quickly as possible (within 30 seconds).

[0212] The sample is then placed in the dark at ambient temperature for 15 minutes to promote the formation of a homogenous film.

[0213] - Measurement of the transmittance of the sample-treated plate The sample-treated plates are analyzed spectrophotometrically to determine the average transmittance of UV radiation through the samples at each wavelength from 290 nm to 400 nm (using monochromatic absorbance data measured at various zones of the plate).

[0214] -Number of measurements

[0215] At least three PMMA plates must be prepared for each sample. Each plate must be measured in at least nine different areas, unless nearly the entire surface of the plate is to be measured spectrophotometrically.

[0216] - In vitro SPF calculation (sun protection factor)

[0217] This is done using the absorbance data A(λ) before and after irradiation at doses of 5 MED and 10 MED according to the following formula:

number

[0218] -Photostability calculation

number

[0219] The compositions according to the invention can be classified according to the following categories as a function of their photostability:

[0220] [Table 11]

[0221] IV.3. Results

[0222] For Formulation 1 and Formulation 2, the following results were obtained: [Table 12]

[0223] V. Assessment of ocular tolerance

[0224] V.1. In vitro model of reconstructed human corneal epithelium (HCE)

[0225] This test is an alternative to animal testing for assessing ocular irritation to reconstructed human corneal epithelium.

[0226] The principle is based on applying the product to reconstructed human corneal epithelium and measuring the average cytotoxicity index over a 24-hour period.

[0227] Cell viability is studied by reducing MTT incorporated into viable cells to a tetrazolium salt that forms purple crystals that can be measured colorimetrically.

[0228] The calculated parameters are MCI 24h ("average cytotoxicity index" over 24 hours), i.e., the average death rate per hour, which allows one to determine whether a product is an irritant.

[0229] This method is described in the paper by Doucet et al., Toxicology in vitro, 2006, 20, 499-512.

[0230] The composition according to the present invention is 24h As a function of

[0231] [Table 13]

[0232] V.2. “Neutral Red Release” method (NRR)

[0233] This test is an alternative to animal testing for assessing eye irritation potential.

[0234] The principle is based on assessing cytotoxicity by determining the concentration causing 50% mortality (CL50) using the neutral red release assay on SIRC rabbit corneal fibroblasts after a contact time of 30 or 60 seconds.

[0235] This method is described in a decree of December 27, 1999, published in the French Official Journal of December 30, 1999.

[0236] After incubation of plated cells with Neutral Red stain, each product dilution is allowed to contact the cells for 60 or 30 seconds, then rinsed away. Cell viability is assessed spectrophotometrically after the addition of release solution.

[0237] The cytotoxicity of a product is indicated by a four-category scale published in the French Official Gazette of December 30, 1999: [Table 14]

[0238] V.3. Results

[0239] Formulation 1 gave the following results: [Table 15]

[0240] VI. Sensory Evaluation of Compositions According to the Invention in Consumer Use Tests

[0241] The purpose of this test is to characterize the perception and sensation during use of the compositions according to the invention and to determine their advantages and disadvantages under real-life conditions of use.

[0242] Seventy-eight consumers aged 18 to 65 (average age 42) were recruited in France, and 84% had sensitive skin.

[0243] These consumers evaluated the product equivalent to Formulation 2 at home.

[0244] Products were evaluated anonymously over a 14-day use period, with evaluations required at the time of application, 1 day later, and 14 days later.

[0245] It should be noted that no intolerance leading to discontinuation of the study was observed.

[0246] The following usage protocol was given to the consumer.

[0247] Apply this composition to your neck and face before going out, instead of your regular sunscreen.

[0248] Reapply frequently, especially after sweating, swimming, or wiping skin.

[0249] [Table 16]

[0250] The sun care product compositions according to the invention certainly have an optimal feel, which is manifested especially during use tests by the products being easy to apply and spread and, once applied, giving the skin a non-greasy, non-sticky appearance, and also providing a very good tactile and visual sensation for the consumer.

Claims

1. A cosmetic or dermatological composition in the form of an emulsion, comprising (a) a lipid-soluble photoprotective system comprising: (i) hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate, (ii) 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine, (iii) butyl methoxydibenzoylmethane, (iv) ethylhexyl triazone, and (v) diethylhexylbutamidotriazone, a lipid-soluble photoprotection system consisting of one or more lipid-soluble UV filters selected from the group consisting of: (b) a solubilization system of the lipid-soluble photoprotective system (a), comprising C in an amount of 80 wt. % or more based on the total weight of the solubilization system; 12 -C 15 a solubilizing system comprising an alkyl benzoate; and (c) one or more particulate organic UV filters, (vi) 5,6,5',6'-tetraphenyl-3,3'-(1,4-phenylene)-bis[1,2,4]triazine, (vii) methylene bis-benzotriazolyl tetramethylbutylphenol, and (viii) tris-biphenyltriazine, A filter selected from Includes; the lipid-soluble photoprotective system (a) is present in an amount ranging from 3% by weight to 19% by weight relative to the total weight of the composition; and the solubilizing system (b) represents from 15 wt.% to 30 wt.% relative to the total weight of the composition; The present invention is characterized in that: The composition does not contain ethylhexyl salicylate, octocrylene, ethylhexyl methoxycinnamate, isoamyl methoxyl cinnamate, homosalate, para-aminobenzoic acid (PABA), octyl dimethyl PABA, 3-methylbenzylidene camphor, 4-methylbenzylidene camphor, benzophenone-3 and / or benzophenone-4.

2. The solubilization system (b) is C 12 -C 15 Preferably selected from alkyl benzoates, caprylic / capric triglyceride, dicaprylyl carbonate, cococaprylate, diisopropyl sebacate, diethylhexyl succinate, isopropyl palmitate, isopropyl myristate, propyl heptyl caprylate, phenethyl benzoate, dibutyl adipate, diisopropyl adipate, glyceryl tri-2-ethylhexanoate, pentaerythrityl tetra-2-ethylhexanoate, cetyl 2-ethylhexanoate, isononyl isononanoate, butylene glycol dicaprylate / dicaprate, octyldodecanol, propylene glycol dicaprylate / dicaprate and dicaprylyl ether. 12 -C 15 2. The composition according to claim 1, characterized in that it comprises one or more lipophilic emollients chosen from alkyl benzoates, caprylic / capric triglycerides and dicaprylyl carbonate.

3. 2. The composition according to claim 1, characterized in that the one or more particulate organic UV filters (c) are present in an amount ranging from 1 wt. % to 8 wt. % relative to the total weight of the composition.

4. 2. The composition according to claim 1, characterized in that the lipid-soluble photoprotection system (a) consists of a combination of the following lipid-soluble filters: (a1) Hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate, 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine and ethylhexyl triazone; (a2) hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate, 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine and diethylhexylbutamidotriazone; (a3) 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine and ethylhexyl triazone; (a4) 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine and diethylhexylbutamidotriazone; (a5) hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate, butyl methoxydibenzoylmethane, 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine and ethylhexyl triazone; (a6) hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate, butyl methoxydibenzoylmethane, 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine and diethylhexylbutamidotriazone; (a7) butyl methoxydibenzoylmethane, 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine and ethylhexyl triazone; and (a8) Butyl methoxydibenzoylmethane, 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine and diethylhexylbutamidotriazone.

5. 5. The composition according to claim 4, characterized in that the fat-soluble photoprotection system (a) consists of a combination of fat-soluble filters (a1).

6. 2. Composition according to claim 1, characterized in that the weight ratio of lipid-soluble photoprotective system (a) / solubilizing system (b) is greater than or equal to 0.

5.

7. Lipid-soluble photoprotective system (a) / C 12 -C 15 2. The composition according to claim 1, characterized in that the weight ratio of alkyl benzoate is 0.5 or more.

8. 2. Composition according to claim 1, characterized in that the weight ratio of particulate organic UV filters (c) to liposoluble photoprotective system (a) is less than or equal to 0.

35.

9. 2. The composition according to claim 1, characterized in that it contains 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine in an amount ranging from 1 wt. % to 4 wt. % relative to the total weight of the composition.

10. 2. The composition according to claim 1, characterized in that it contains hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate in an amount ranging from 1 wt. % to 10 wt. % relative to the total weight of the composition.

11. 2. The composition according to claim 1, comprising ethylhexyl triazone in an amount ranging from 1 wt. % to 6 wt. % relative to the total weight of the composition.

12. 2. The composition of claim 1, wherein the one or more particulate organic filters (c) comprise a single aqueous-dispersed organic filter which is 5,6,5',6'-tetraphenyl-3,3'-(1,4-phenylene)-bis[1,2,4]triazine.

13. 2. The composition according to claim 1, characterized in that the total number of UV filters present in the composition is 5 or less, and that all UV filters present in the composition comprise from 4 wt. % to 25 wt. % relative to the total weight of the composition.

14. C 1- C 4 2. The composition according to claim 1, characterized in that it contains alcohol in an amount of 4 wt. % or less relative to the total weight of the composition.

15. 2. The composition according to claim 1, further comprising one or more particulate inorganic filters.

16. 2. The composition according to claim 1, characterized in that it further comprises one or more texturizing agents in powder form chosen from the members of the starch family; talc and cellulose, in an amount comprised between 1 wt% and 10 wt% relative to the total weight of the composition.

17. The solubilization system (b) is C 12 -C 15 2. The composition according to claim 1, characterized in that it comprises one or more lipophilic emollients chosen from alkyl benzoates and caprylic / capric triglycerides.

18. The solubilization system of the lipid-soluble photoprotective system (a) contains 90 wt % or more of C based on the total weight of the solubilization system. 12 -C 15 Contains alkyl benzoate; 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine is present in an amount of 2 wt % to 3 wt %, based on the total weight of the composition; hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate is present in an amount of 5 wt % to 6 wt %, based on the total weight of the composition; ethylhexyl triazone is present in an amount of 3.5 wt.% to 4.5 wt.%, based on the total weight of the composition; the one or more particulate organic filters (c) comprise a single aqueous-dispersed organic filter which is 5,6,5',6'-tetraphenyl-3,3'-(1,4-phenylene)-bis[1,2,4]triazine, present in an amount of 2 wt % to 5 wt %, based on the total weight of the composition; Characterized in that the total number of UV filters present in the composition is equal to 4, 2. The composition of claim 1.

19. The one or more particulate organic filters (c) have a particle size D of 100 to 1000 nm. 50 and is present in an amount of 3 wt% to 4 wt% based on the total weight of the composition.

20. The composition according to any one of claims 1 to 19 for protecting the skin and / or hair from ultraviolet radiation.